Genprex Free Cash Flow Per Share from 2010 to 2025

GNPX Stock  USD 0.36  0.01  3.95%   
Genprex Free Cash Flow Per Share yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Per Share will likely drop to -21.92 in 2025. Free Cash Flow Per Share is the amount of cash Genprex generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
(20.87)
Current Value
(21.92)
Quarterly Volatility
4.51413162
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Genprex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genprex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 K, Interest Expense of 21.9 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.85. Genprex financial statements analysis is a perfect complement when working with Genprex Valuation or Volatility modules.
  
Check out the analysis of Genprex Correlation against competitors.
For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Latest Genprex's Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of Genprex over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Genprex's Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genprex's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

Genprex Free Cash Flow Per Share Regression Statistics

Arithmetic Mean(15.72)
Geometric Mean14.87
Coefficient Of Variation(28.72)
Mean Deviation3.10
Median(15.42)
Standard Deviation4.51
Sample Variance20.38
Range16.9652
R-Value(0.38)
Mean Square Error18.76
R-Squared0.14
Significance0.15
Slope(0.36)
Total Sum of Squares305.66

Genprex Free Cash Flow Per Share History

2025 -21.92
2024 -20.87
2023 -18.15
2022 -14.89
2021 -12.21
2020 -18.32
2019 -19.66

About Genprex Financial Statements

Genprex investors use historical fundamental indicators, such as Genprex's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genprex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share(20.87)(21.92)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.